SGN-B6A compared with docetaxel in previously treated NSCLC

A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer

Disease Types: Lung

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A randomized, phase 3, open-label study to evaluate SGN-B6A compared with docetaxel in adult subjects with previously treated non-small cell lung cancer 

For More Information:

https://clinicaltrials.gov/study/NCT06012435?term=A%20randomized,%20phase%203,%20open-label%20study%20to%20evaluate%20SGN-B6A%20compared%20with%20docetaxel%20in%20adult%20subjects%20with%20previously%20treated%20non-small%20cell%20lung%20cancer%20&rank=1